SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 07 Sep 2022
Last Applicant/ Owned by
86 MORRIS AVENUE
SUMMIT
NJ
07901
Serial Number
86690908 filed on 13th Jul 2015
Registration Number
4931750 registered on 05th Apr 2016
Filing Basis
1. intent to use
Disclaimer
NO DATA
INREBIC
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, [ autoinflammatory disease, autoimmune disease, ] blood disease, cancer, [ arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; ] pharmaceutical preparations, namely, cytokine inhibitory drugs; [ pharmaceutical preparations that modulate the immune s Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, [ autoinflammatory disease, autoimmune disease, ] blood disease, cancer, [ arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; ] pharmaceutical preparations, namely, cytokine inhibitory drugs; [ pharmaceutical preparations that modulate the immune system ]
Mark Details
Serial Number
No 86690908
Mark Type
No Service/Collective Mark
Attorney Docket Number
No CELG1386US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Sep 2022 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 07th Sep 2022 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 07th Sep 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 15th Mar 2022 | TEAS SECTION 8 & 15 RECEIVED |
| 05th Apr 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 06th Feb 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 05th Apr 2016 | REGISTERED-PRINCIPAL REGISTER |
| 19th Jan 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Jan 2016 | PUBLISHED FOR OPPOSITION |
| 30th Dec 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |